AMMAN M. G. , SINGH N. N. , STEWART A. W. , FIELD C. J.Psychometric characteristics of the Aberrant Behavior Checklist . Am J Ment Def1985;99: 492-502 .
2.
CHEZ M. G. , AIMONOVITCH M. , BUCHANAN T. , MRAZEK S. , TREMB R. J.Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate . J Child Neurol2004;19: 165-169
3.
BIRMAHER B. , QUINTANA H. , GREENHILL L. L.Methylphenidate treatment of hyperactive autistic children . J Am Acad Child Adolesc Psychiatry1988;27: 248-251 .
4.
HERTZMAN M.Galantamine in the treatment of adult autism: a report of three clinical cases . Int J Psychiatry Med, 2003;33: 395-398
5.
JASELSKIS C. A. , COOK E. H. , FLETEHER K. E. , LEVENTHAL B. L.Clonidine treatment of Hyperactive and Impulsive Children with Autistic DisorderJ Clin Psychopharm, 1992;5: 322-327
6.
POSEY D. J. , LITWILLER M. , KOBURN A. , MCDOUGLE C. J.Paroxetine in autism . J Am Child Adol Psychiatry1999;38: 111-112
7.
PURPER -OUAKIL D. , FOURNERET P. , WOHL M. , RENERIC J. P.Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescentsEncephale. 2005;31: 337-348 .
8.
HOWLIN, P. & ASGHARIAN, A. (1999) ‘The diagnosis of autism and Asperger’s syndrome: findings from a survey of 770 families’ , Developmental Medicine and Child Neurology, 41: 834-839 .
9.
HOWLIN, P. & MOORE, A. (1997) ‘Diagnosis of autism: a survey of over 1200 patients in the UK’ , Autism, 1 (2): 135-162 .
10.
LE COUTEUR, A. (2003) ‘National Action Plan for Autism’: The National Autistic Society Initiative for Autism: Screening and Assessment.
11.
SMITH, B. , CHUNG, M. C. , & VOSTANIS, P. (1994) The path to care in autism: Is it better now , Journal of Autism and Developmental Disorders, 24 (5): 551-563 .